Press release BrainLit – New CEO

As of May 2, Niclas Möttus Olsson is new CEO for BrainLit, the company that has invented the BioCentric Lighting™. Niclas has a very extensive international experience mainly from the Life Science and the Health Care business. He has held executive positions in Asia and the USA and moved recently back to Sweden with his family. 

Press release

BrainLit – New CEO

5/02/2019

As of May 2, Niclas Möttus Olsson is new CEO for BrainLit, the company that has invented the BioCentric Lighting™. Niclas has a very extensive international experience mainly from the Life Science and the Health Care business. He has held executive positions in Asia and the USA and moved recently back to Sweden with his family. ‘BrainLit is still a young company with a very promising future lying ahead. To step up and make BrainLit truly international we looked for a twenty-first-century leader with documented sales & marketing experience along with an extensive international network, when our current CEO Ofelia Madsen decided to leave. When Niclas name came up, we really thought it was a perfect match,’ says Mats Leifland chairman of the board at BrainLit.

’ says Niclas. ‘BrainLit has such a great potential to become the global leader in the industry and can help people to feel better and to hold back several of the modern world illnesses’ Niclas continues.

BrainLit started off in 2015 and has several successful installations at schools, in hospitals, in conference rooms et al. and has recently started its international expansion through the installation at the Consulate General of Sweden in Hong Kong.

‘We have very high aspirations with BrainLit, and with Niclas at the helm, I’m positive we’ll develop as we hope and will reach our ambitious growth targets’ finishes Mats.

For further information:

Niclas Olsson                                                       Mats Leifland
CEO                                                                     Chairman of the Board
BrainLit AB                                                           BrainLit AB     
Tel: + 46 720 255 563                                          Tel: + 46 733 371 006

niclas.olsson@brainlit.se

                                                   

BrainLit sustains the natural rhythm of life by developing personalized light. The company is a solution provider of BioCentric Lighting™ systems. BrainLit delivers all required software, hardware, and hands over a turn-key lighting solution adapted to the customers’ environment and needs. The educational program BrainLit provides, ensure that the lighting solution is optimal to benefit the well-being of the people exposed to the light.

BrainLit sustains the natural rhythm of life by developing personalized light. The company is a solution provider of BioCentric Lighting™ systems. BrainLit delivers all required software and hardware, and hands over a turn-key lighting solution adapted to the customers’ environment and needs. The educational program BrainLitprovides, ensure that the lighting solution is optimal to benefit the well-being of thepeople exposed to the light.

Tags:

About Us

BrainLit sustains the natural rhythm of life by developing personalized light. The company is a solution provider of BioCentric Lighting™ systems. BrainLit delivers all required software and hardware and hands over a turn-key lighting solution adaptedto the customers’ environment and needs. The educational program BrainLitprovides, ensure that the lighting solution is optimal to benefit the well-being of thepeople exposed to the light.

Subscribe

Media

Media

Documents & Links

Quotes

To take up the challenge and make BrainLit a global company, was just an offer far too tempting, to reject
- Niclas Olsson, CEO
We have very high aspirations with BrainLit, and with Niclas at the helm, I’m positive we’ll develop as we hope and will reach our ambitious growth targets.
Mats Leifland, Chairman of the Board
BrainLit has such a great potential to become the global leader in the industry and can help people to feel better and to hold back several of the modern world illnesses.
Niclas Olsson, CEO